In the latest trading session, Viking Therapeutics, Inc. (VKTX) closed at $62.45, marking a -0.3% move from the previous day. The stock trailed the S&P 500, which registered a daily loss of 0.21%.
In a report released today, Joon Lee from Truist Financial assigned a Buy rating to Viking Therapeutics (VKTX – Research Report). The ...
On Monday, Viking Therapeutics Inc (VKTX) stock saw a modest uptick, ending the day at $63.31 which represents a slight increase of $1.68 or 2.73% from the prior close of $61.63. The stock opened at ...
Viking Therapeutics, Inc. (VKTX) ended the recent trading session at $64.11, demonstrating a -0.9% swing from the preceding day's closing price. This change lagged the S&P 500's 0.17% loss on the ...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sanofi (SNYNF – Research Report) and Viking ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
On Wednesday, Viking Therapeutics Inc. (NASDAQ:VKTX) released data from the Phase 1b trial of VK0214, a novel small molecule ...